- Home
- CTRI vs IMCR Comparison
CTRI vs IMCR Comparison
Compare CTRI & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRI
- IMCR
- Stock Information
- Founded
- CTRI 1909
- IMCR 2008
- Country
- CTRI United States
- IMCR United Kingdom
- Employees
- CTRI N/A
- IMCR N/A
- Industry
- CTRI
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CTRI
- IMCR Health Care
- Exchange
- CTRI Nasdaq
- IMCR Nasdaq
- Market Cap
- CTRI 1.8B
- IMCR 1.4B
- IPO Year
- CTRI 2024
- IMCR 2021
- Fundamental
- Price
- CTRI $18.55
- IMCR $30.16
- Analyst Decision
- CTRI Hold
- IMCR Buy
- Analyst Count
- CTRI 7
- IMCR 12
- Target Price
- CTRI $19.00
- IMCR $60.90
- AVG Volume (30 Days)
- CTRI 261.7K
- IMCR 376.7K
- Earning Date
- CTRI 05-07-2025
- IMCR 05-07-2025
- Dividend Yield
- CTRI N/A
- IMCR N/A
- EPS Growth
- CTRI N/A
- IMCR N/A
- EPS
- CTRI N/A
- IMCR N/A
- Revenue
- CTRI $2,637,229,000.00
- IMCR $310,202,000.00
- Revenue This Year
- CTRI $4.12
- IMCR $20.52
- Revenue Next Year
- CTRI $4.84
- IMCR $8.57
- P/E Ratio
- CTRI N/A
- IMCR N/A
- Revenue Growth
- CTRI N/A
- IMCR 24.36
- 52 Week Low
- CTRI $14.46
- IMCR $23.15
- 52 Week High
- CTRI $28.65
- IMCR $62.74
- Technical
- Relative Strength Index (RSI)
- CTRI N/A
- IMCR 59.11
- Support Level
- CTRI N/A
- IMCR $27.55
- Resistance Level
- CTRI N/A
- IMCR $30.85
- Average True Range (ATR)
- CTRI 0.00
- IMCR 1.95
- MACD
- CTRI 0.00
- IMCR 0.44
- Stochastic Oscillator
- CTRI 0.00
- IMCR 89.02
About CTRI Centuri Holdings Inc. Common Stock
Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings primarily consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. They operate under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.